Eyetcch Pharmaceuticals, Inc., a company that develops treatments 1″01″ eye problems, went public in…


Eyetcch Pharmaceuticals, Inc., a aggregation that develops treatments 1"01" eye problems, went common in January 2004. Assisted by the siege bank Merrill Lynch, Eyetech sold 6.5 darling divides at $21 each. There by amelioration a entirety of $136.5 darling. At the end of the primary day of trading, the hoard sold for $32.40 per divide, down subordinately from a lofty of $33.00. Based on the el1d~of-day total, Eyetech divides were right underpriced by about $11 each, significance that the aggregation missed out on  an attached $67 darling. IPO Pricing, The Eyetech IPO Pricing. In the prior topic. would it influence your thinking to perceive that the aggregation was incorporated hither than foul-mouthed years precedent. had barely $30 darling in revenues for the primary nine months of 2003, and had never earned a avail? Additionally. the aggregation had barely one issue. Macugen. which had won fast-track condition from the FDA. but quiescent did not own encomium to be sold.